(Q88171222)
Statements
Autologous bone marrow mononuclear cell therapy improves symptoms in patients with end-stage peripheral arterial disease and reduces inflammation-associated parameters (English)
Nasser M Malyar
Khalil Malyar
Jawed Arjumand
Peter A Horn
Knut Kröger
Eva Freisinger
Holger Reinecke
Franz-Eduard Brock